Nigeria vs Spain: Access to anti-retroviral drugs, female
Nigeria
89.0%
in 2024
Spain
89.0%
in 2022
Nigeria rank
35th
Spain rank
35th
Access to anti-retroviral drugs, female over time
- Nigeria
- Spain
How they compare
Nigeria currently reports 89.0% against 89.0% in Spain, a difference of 0.0%.
Across all 23 years both countries report, Spain has been ahead every year.
Nigeria ranks 35th and Spain ranks 35th of 141 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nigeria | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.0% | 55.8% | 50.8% | Spain |
| 2010s | 43.4% | 83.5% | 40.1% | Spain |
| 2020s | 73.0% | 87.0% | 14.0% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Nigeria or Spain?
- Nigeria, at 89.0% against 89.0% in Spain as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Nigeria and Spain?
- 0.0%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Spain?
- 23 years are reported by both, from 2000 to 2022.
- How do Nigeria and Spain rank globally for access to anti-retroviral drugs, female?
- Nigeria ranks 35th and Spain ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.